arrow_back Back to App

Free COVID-19 Antibody Treatments: New Rules for Health Insurance

This act requires health plans and insurers to cover the costs of COVID-19 antibody treatments without additional charges to patients. This means individuals with a positive COVID-19 test result who need antibody treatment will not have to pay out-of-pocket for these therapies or their administration.
Key points
Health insurance must cover FDA-approved COVID-19 antibody treatments.
Patients will not incur any additional costs for these therapies or their administration.
Changes apply to individuals with a positive COVID-19 test result who qualify for antibody treatment.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_467
Sponsor: Rep. Gonzalez, Anthony [R-OH-16]
Process start date: 2021-01-25
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Protecting Patient Access to Lifesaving COVID–19 Drugs Act of 2021

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_467.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-01-25.

What are the main provisions?

Key points include:

  • Health insurance must cover FDA-approved COVID-19 antibody treatments.
  • Patients will not incur any additional costs for these therapies or their administration.
  • Changes apply to individuals with a positive COVID-19 test result who qualify for antibody treatment.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Gonzalez, Anthony [R-OH-16].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health